These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2931251)

  • 1. Differential susceptibility of BALB/c sublines to diabetes induction by multi-dose streptozotocin treatment.
    Leiter EH
    Curr Top Microbiol Immunol; 1985; 122():78-85. PubMed ID: 2931251
    [No Abstract]   [Full Text] [Related]  

  • 2. Resolution of streptozotocin-induced diabetes mellitus by pancreatic transplantation in inbred mice.
    Pollak R; Blanchard JM; Welsh T
    Transplantation; 1988 Oct; 46(4):611-3. PubMed ID: 2972096
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple low-dose streptozotocin-induced hyperglycemia and insulitis in C57BL mice: influence of inbred background, sex, and thymus.
    Leiter EH
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):630-4. PubMed ID: 6210909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of insulin-dependent diabetes by streptozotocin. Inhibition by estrogens and potentiation by androgens.
    Paik SG; Michelis MA; Kim YT; Shin S
    Diabetes; 1982 Aug; 31(8 Pt 1):724-9. PubMed ID: 6219020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and environmental control of diabetes induction by multi-dose streptozotocin in two BALB/c substrains.
    Leiter EH; Le PH; Prochazka M; Worthen SM; Huppi K
    Diabetes Res; 1988 Sep; 9(1):5-10. PubMed ID: 2977107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The induction of diabetes in rats by intramuscular administration of streptozotocin.
    Nakhoda A; Wong HA
    Experientia; 1979 Dec; 35(12):1679-80. PubMed ID: 160326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia in BALB/c mice after pretreatment with one subdiabetogenic dose of streptozotocin and subsequent infection with a Coxsackie B4 strain.
    Wegner U; Kewitsch A; Madauss M; Döhner L; Zühlke H
    Biomed Biochim Acta; 1985; 44(1):21-7. PubMed ID: 2986611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Streptozotocin-induced non-insulin dependent diabetes mellitus in rats].
    Somova L; Dashev G; Doncheva M; Vasileva M
    Eksp Med Morfol; 1988; 27(3):9-17. PubMed ID: 2975593
    [No Abstract]   [Full Text] [Related]  

  • 9. Streptozotocin-induced diabetic models in mice and rats.
    Wu KK; Huan Y
    Curr Protoc Pharmacol; 2008 Mar; Chapter 5():Unit 5.47. PubMed ID: 22294227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes.
    Paik SG; Fleischer N; Shin SI
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6129-33. PubMed ID: 6449703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of experimental autoimmune diabetes by low-dose streptozotocin treatment in genetically resistant mice.
    Kiesel U; Greulich B; Moumé CM; Kolb H
    Immunol Lett; 1981 Oct; 3(4):227-30. PubMed ID: 7309132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.
    Herold KC; Baumann E; Vezys V; Buckingham F
    J Autoimmun; 1997 Feb; 10(1):17-25. PubMed ID: 9080296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes induction by subdiabetogenic doses of streptozotocin in BALB/cBOM mice. Noninvolvement of host B-lymphocyte functions.
    Blue ML; Shin SI
    Diabetes; 1984 Feb; 33(2):105-10. PubMed ID: 6229438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells and ST2 signaling control diabetes induction with multiple low doses of streptozotocin.
    Zdravkovic N; Shahin A; Arsenijevic N; Lukic ML; Mensah-Brown EP
    Mol Immunol; 2009 Nov; 47(1):28-36. PubMed ID: 19356801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes.
    Flodström M; Tyrberg B; Eizirik DL; Sandler S
    Diabetes; 1999 Apr; 48(4):706-13. PubMed ID: 10102685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of genetic background on the susceptibility of inbred mice to streptozotocin-induced diabetes.
    Wolf J; Lilly F; Shin SI
    Diabetes; 1984 Jun; 33(6):567-71. PubMed ID: 6233198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet beta-cytotoxic monoclonal antibody against glycolipids in experimental diabetes induced by low dose streptozotocin and Freund's adjuvant.
    Ziegler M; Teneberg S; Witt S; Ziegler B; Hehmke B; Kohnert KD; Egeberg J; Karlsson KA; Lernmark A
    J Immunol; 1988 Jun; 140(12):4144-50. PubMed ID: 2967328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganglioside therapy of type I diabetes: enhancement of hyperglycemia in the low dose streptozotocin model.
    Zielasek J; Kolb H
    Life Sci; 1992; 51(1):49-52. PubMed ID: 1535407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of single high-dose streptozotocin with partial pancreatectomy combined with low-dose streptozotocin for diabetes induction in rhesus monkeys.
    Jin X; Zeng L; He S; Chen Y; Tian B; Mai G; Yang G; Wei L; Zhang Y; Li H; Wang L; Qiao C; Cheng J; Lu Y
    Exp Biol Med (Maywood); 2010 Jul; 235(7):877-85. PubMed ID: 20558842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes.
    Mueller R; Lee MS; Sawyer SP; Sarvetnick N
    J Autoimmun; 1996 Apr; 9(2):151-8. PubMed ID: 8738958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.